Vinorelbine
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4589 publications
Sacituzumab govitecan in ER+/HER2- breast cancer: a necessary treatment option for patients who have undergone multiple prior treatments.
Journal: Recenti progressi in medicina
Published: September 02, 2026
Hypereosinophilic syndrome and suspected myeloid neoplasia in relapsed Hodgkin lymphoma during immune checkpoint inhibitor therapy: a rare case.
Journal: Leukemia & lymphoma
Published: August 30, 2026
DPYD-Guided Dosing of Metronomic Capecitabine Plus Vinorelbine in Metastatic Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Real-World Retrospective Study.
Journal: JCO precision oncology
Published: August 07, 2026
Occult Pulmonary Adenosquamous Carcinoma Presenting With Synchronous Colonic Metastases.
Journal: The American surgeon
Published: June 26, 2026
BEGEV as Salvage Therapy in Relapsed/Refractory Non-Hodgkin Lymphoma: Real-World Outcomes and Transplantation Feasibility.
Journal: Medicina (Kaunas, Lithuania)
Published: June 25, 2026
Performance status 2 or higher in EMA labels for advanced non-small-cell lung cancer: a cross-sectional SmPC analysis.
Journal: Cancer treatment and research communications
Published: May 22, 2026
Integrating single-cell and bulk RNA data to explore the prognostic significance of LIM domain family genes in colorectal cancer and unveil their immune landscape.
Journal: Translational oncology
Published: May 21, 2026
Afatinib combined with oral metronomic vinorelbine as second-line treatment for advanced lung squamous cell carcinoma: a retrospective cohort study.
Journal: Neoplasma
Published: May 07, 2026
Alkaloids mediated regulation of microRNA in cancer: molecular insights and emerging therapeutic strategies.
Journal: Frontiers in oncology
Published: April 23, 2026
Last Updated: 09/26/2026